Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Haoran Bio-Pharma is a China-based biopharmaceutical manufacturer focused on nature-sourced protein drugs, including APIs, intermediates, and finished preparations. The company specializes in active substances derived from human urine and animal organs and has built technical capabilities in large-scale medicinal protein extraction, purification, and quality control. Its marketed product portfolio includes urokinase, ulinastatin, chorionic gonadotropin, urofollitropin, menotropins, kallidinogenase, and related heparin-series products. Haoran operates manufacturing facilities in Nanchang, Jiangxi, and states that its systems comply with China GMP and international cGMP expectations, with inspections by regulators including PMDA, MFDS, and FDA referenced on company materials. Commercially, the company appears oriented toward reproductive medicine, cardiovascular/thrombolytic care, and critical care markets in China and export territories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Haoran Bio-Pharma.